Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis

R. P. McQuellon; B. W. Loggie; R. A. Fleming; G. B. Russell; A. B. Lehman; T. D. Rambo

doi:10.1053/ejso.2000.1033

Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis

R. P. McQuellon, B. W. Loggie, R. A. Fleming, G. B. Russell, A. B. Lehman, T. D. Rambo

Research output: Contribution to journal › Article › peer-review

139 Scopus citations

Abstract

Aims: This study assessed the functional status and quality of life (QOL) of patients with disseminated peritoneal cancer (DPC) before and after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy (IPHC). Methods: Patients with confirmed or suspected diagnosis of gastro-intestinal cancer including stomach, pancreas, hepatobiliary and colorectal cancer with peritoneal implants were enrolled in the study. Sixty-four patients completed the Functional Assessment of Cancer Therapy-Colon (FACT-C) scale and several other instruments at baseline. Forty-eight, 40, 39 and 31 patients were assessed at approximately 2 weeks post-surgery, and 3, 6 and 12 months respectively. Results. There was a significant overall effect on the physical (P=0.0025), emotional (P

Original language	English (US)
Pages (from-to)	65-73
Number of pages	9
Journal	European Journal of Surgical Oncology
Volume	27
Issue number	1
DOIs	https://doi.org/10.1053/ejso.2000.1033
State	Published - 2001
Externally published	Yes

All Science Journal Classification (ASJC) codes

Surgery
Oncology

Access to Document

10.1053/ejso.2000.1033

Fingerprint Dive into the research topics of 'Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis'. Together they form a unique fingerprint.

Cite this

@article{05ac215a13af4e2c99c452a7649a00f4,

title = "Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis",

abstract = "Aims: This study assessed the functional status and quality of life (QOL) of patients with disseminated peritoneal cancer (DPC) before and after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy (IPHC). Methods: Patients with confirmed or suspected diagnosis of gastro-intestinal cancer including stomach, pancreas, hepatobiliary and colorectal cancer with peritoneal implants were enrolled in the study. Sixty-four patients completed the Functional Assessment of Cancer Therapy-Colon (FACT-C) scale and several other instruments at baseline. Forty-eight, 40, 39 and 31 patients were assessed at approximately 2 weeks post-surgery, and 3, 6 and 12 months respectively. Results. There was a significant overall effect on the physical (P=0.0025), emotional (P",

author = "McQuellon, {R. P.} and Loggie, {B. W.} and Fleming, {R. A.} and Russell, {G. B.} and Lehman, {A. B.} and Rambo, {T. D.}",

note = "Funding Information: This study was supported in part by grants CA-67809 and CA-12197 from the National Institutes of Health.",

year = "2001",

doi = "10.1053/ejso.2000.1033",

language = "English (US)",

volume = "27",

pages = "65--73",

journal = "European Journal of Surgical Oncology",

issn = "0748-7983",

publisher = "W.B. Saunders Ltd",

number = "1",

}

TY - JOUR

T1 - Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis

AU - McQuellon, R. P.

AU - Loggie, B. W.

AU - Fleming, R. A.

AU - Russell, G. B.

AU - Lehman, A. B.

AU - Rambo, T. D.

N1 - Funding Information: This study was supported in part by grants CA-67809 and CA-12197 from the National Institutes of Health.

PY - 2001

Y1 - 2001

N2 - Aims: This study assessed the functional status and quality of life (QOL) of patients with disseminated peritoneal cancer (DPC) before and after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy (IPHC). Methods: Patients with confirmed or suspected diagnosis of gastro-intestinal cancer including stomach, pancreas, hepatobiliary and colorectal cancer with peritoneal implants were enrolled in the study. Sixty-four patients completed the Functional Assessment of Cancer Therapy-Colon (FACT-C) scale and several other instruments at baseline. Forty-eight, 40, 39 and 31 patients were assessed at approximately 2 weeks post-surgery, and 3, 6 and 12 months respectively. Results. There was a significant overall effect on the physical (P=0.0025), emotional (P

AB - Aims: This study assessed the functional status and quality of life (QOL) of patients with disseminated peritoneal cancer (DPC) before and after cytoreductive surgery plus intraperitoneal hyperthermic chemotherapy (IPHC). Methods: Patients with confirmed or suspected diagnosis of gastro-intestinal cancer including stomach, pancreas, hepatobiliary and colorectal cancer with peritoneal implants were enrolled in the study. Sixty-four patients completed the Functional Assessment of Cancer Therapy-Colon (FACT-C) scale and several other instruments at baseline. Forty-eight, 40, 39 and 31 patients were assessed at approximately 2 weeks post-surgery, and 3, 6 and 12 months respectively. Results. There was a significant overall effect on the physical (P=0.0025), emotional (P

UR - http://www.scopus.com/inward/record.url?scp=0035092594&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035092594&partnerID=8YFLogxK

U2 - 10.1053/ejso.2000.1033

DO - 10.1053/ejso.2000.1033

M3 - Article

C2 - 11237495

AN - SCOPUS:0035092594

VL - 27

SP - 65

EP - 73

JO - European Journal of Surgical Oncology

JF - European Journal of Surgical Oncology

SN - 0748-7983

IS - 1

ER -

Quality of life after intraperitoneal hyperthermic chemotherapy (IPHC) for peritoneal carcinomatosis

Abstract

All Science Journal Classification (ASJC) codes

Access to Document

Other files and links

Cite this